IGF-IR β Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of IGF-IR β Antibodies for research focused on understanding insulin-like growth factor receptor signaling pathways. IGF-IR β Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IGF-IR β plays a crucial role in cell growth, differentiation, and survival, making it a significant focus in cancer research and metabolic studies. The activation of IGF-IR β is linked to various physiological processes, including development and aging. Dysregulation of IGF-IR signaling has been implicated in numerous diseases, including diabetes and cancer. Understanding IGF-IR β function is essential for developing targeted therapies and advancing knowledge of cellular mechanisms. IGF-IR β research using monoclonal antibodies from Santa Cruz Biotechnology enables scientists to make meaningful contributions to therapeutic development and disease understanding. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal antibodies to advance scientific knowledge and drive breakthrough discoveries in IGF-IR β signaling research.